Medication info

Zadilirina Tablets 10/5 mg (Empagliflozin 2L-Proline, Linagliptin)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin 2L-Proline›15.107mg / 1 tabletLinagliptin Micronized›5mg / 1 tablet
Manufacturer / importer
Genewon Science Co., Ltd.
Appearance
Pale yellow triangular film-coated tablets
Packaging
30 tablets / bottle
Approval status
Active

MFDS item code 202502428 · Approved 2025.09.12

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended starting dose of this medicine is empagliflozin 10 mg once daily (15.107mg as empagliflozin 2L-proline)/linagliptin 5 mg. If additional glycemic control is needed and empagliflozin 10 mg/linagliptin 5 mg is tolerated, the dose of this medicine may be increased to 25/5 mg once daily (37.766mg as empagliflozin 2L-proline). Patients switching to this medicine from combination therapy with empagliflozin and linagliptin should receive the same doses they were previously taking. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose of this medicine, take it as soon as you remember. However, if it is within 12 hours of the next dose, skip the missed dose and take the next dose at the usual scheduled time. Do not take a double dose in one day. Patients with renal impairment This medicine is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is needed in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is needed in patients with mild or moderate hepatic impairment. This medicine has not been studied in patients with severe hepatic impairment; therefore, its use is not recommended. Older adults No dose adjustment is needed based on age. In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
Genewon Science Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used to assist patients with type 2 diabetes in controlling their blood sugar levels. It is particularly effective when taken in conjunction with dietary and exercise therapy. The combination of empagliflozin and linagliptin helps to maintain stable blood sugar levels. Therefore, this medication is used as an important adjunct in diabetes treatment.

How to take

Adult dose

The recommended starting dose of this medicine is empagliflozin 10 mg once daily (15.107mg as empagliflozin 2L-proline)/linagliptin 5 mg. If additional glycemic control is needed and empagliflozin 10 mg/linagliptin 5 mg is tolerated, the dose of this medicine may be increased to 25/5 mg once daily (37.766mg as empagliflozin 2L-proline). Patients switching to this medicine from combination therapy with empagliflozin and linagliptin should receive the same doses they were previously taking. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose of this medicine, take it as soon as you remember. However, if it is within 12 hours of the next dose, skip the missed dose and take the next dose at the usual scheduled time. Do not take a double dose in one day. Patients with renal impairment This medicine is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is needed in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is needed in patients with mild or moderate hepatic impairment. This medicine has not been studied in patients with severe hepatic impairment; therefore, its use is not recommended. Older adults No dose adjustment is needed based on age. In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.

Precautions

This medication contains empagliflozin and linagliptin as active ingredients and should not be administered to certain patients. For example, it should not be used in patients who are allergic to its components, those with type 1 diabetes, diabetic ketoacidosis, and patients undergoing dialysis. Additionally, patients with impaired kidney function or congestive heart failure should use this medication cautiously, and if skin conditions such as acute pancreatitis or bullous pemphigoid are suspected, treatment should be discontinued immediately. The most common side effect when taking this medication is urinary tract infection. Rarely, ketoacidosis, pancreatitis, hypersensitivity reactions, and hypoglycemia may occur. Special care is needed when taken in conjunction with insulin or sulfonylureas due to an increased risk of hypoglycemia. Ketoacidosis can occur regardless of blood sugar levels, and symptoms such as nausea, vomiting, abdominal pain, lethargy, and dyspnea should prompt immediate consultation with medical personnel. Patients at risk of dehydration or hypotension should carefully monitor their fluid status while taking this medication. This medication may increase the risk of genital fungal infections, so appropriate treatment is necessary if related symptoms occur. Elderly patients aged 75 or older should pay special attention to potential fluid volume loss. Caution is also advised while driving or operating machinery due to the risk of hypoglycemia, and the risk of limb amputation has been reported, necessitating thorough foot care. It is recommended that women who are pregnant or breastfeeding not use this medication, and it is also not indicated for children under 18 years of age. In case of an overdose, medical attention should be sought immediately, and this medication should be stored out of reach of children. It is also safe to store in the original packaging.

Side effects

Urinary tract infection, vulvovaginitis, vulvitis, balanitis, genital infections, hypersensitivity, angioedema, urticaria, hypoglycemia, thirst, ketosis, cough, constipation, pancreatitis, oral ulcer formation, itching, rash, vesicular-like pemphigus, rhabdomyolysis, hypovolemia, increased urination, dysuria, interstitial nephritis, increased amylase, increased lipase, increased hematocrit, increased serum lipids, increased blood creatinine, decreased glomerular filtration rate, epigastric pain, enterocolitis, intestinal obstruction, gastroenteritis, shingles, cystitis, acute pyelonephritis, bronchitis, vestibular neuronitis, sepsis, pneumonia, decreased appetite, dehydration, hyperglycemia, cerebral infarction, speech disorder, Alzheimer's disease, chest pain, fever, facial swelling, fatigue, death, chronic obstructive pulmonary disease, asthma, diabetic foot, skin lesions, metastasis to the liver, acute leukemia, basal cell carcinoma, non-small cell lung cancer, malignant pericardial effusion, stomach cancer, colorectal cancer, pancreatic cancer, meniscus injury, pneumoconiosis, congestive heart failure, angina pectoris, acute myocardial infarction, unstable angina, cardiac arrest, diabetic retinopathy, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, dizziness, renal transplant failure, abdominal pain, gastrointestinal disorders, irritable bowel syndrome, burning mouth syndrome, colitis, abdominal discomfort, dysphagia, gastric ulcer, gum bleeding, tooth loss, hemorrhoids, lower abdominal pain, diarrhea, vomiting, gastritis, palmoplantar keratoderma, rhinitis, soft tissue infection, pharyngitis, scrub typhus, periodontitis, tonsillitis, laryngitis, chronic otitis media, paronychia, peritonsillar abscess, viral upper respiratory infection, upper respiratory infection, hypercholesterolemia, insufficient control of diabetes, malnutrition, hyponatremia, headache, drowsiness, chest discomfort, asthenia, nosebleed, oral pharyngeal pain, speech disorder, allergic rhinitis, exercise-induced dyspnea, wet cough, arthralgia, osteoporosis, arthropathy, musculoskeletal discomfort, myositis, myalgia, soft tissue mass, postmenopausal osteoporosis, rotator cuff syndrome, increased triglycerides in blood, increased urine albumin/creatinine ratio, positive urine leukocytes, decreased hemoglobin, increased potassium in blood, increased creatinine in blood, increased creatine phosphokinase in blood, increased ALT, androgenetic alopecia, hyperhidrosis, hair loss, dermatitis, anxiety, mood disorders, insomnia, depression, hypertension, hearing loss, vulvar pruritus, genital pruritus, hypoglycemia, obesity, secondary hyperparathyroidism, vitamin D deficiency, dermoid cyst, seborrheic dermatitis, atopic dermatitis, nummular eczema, heat rash, sebaceous gland hyperplasia, lumbar spinal stenosis, myalgia, limb pain, musculoskeletal chest pain, cervical stenosis, fibromyalgia, flank pain, fracture pain, muscle weakness, rotator cuff syndrome, astigmatism, allergic conjunctivitis, blurred vision, corneal erosion, macular fibrosis, conjunctival hyperemia, pathological myopia, retinal deposit, retinal vein occlusion, macular retinal detachment, eyelid swelling, visual impairment, vitreous floaters, vitreous hemorrhage, nasal bleeding, exercise-induced dyspnea, wet cough, residual phlegm, skin laceration, rib fracture, ligamentous strain syndrome, palpitations, tachycardia, atherosclerosis, diabetic vascular complications, peripheral arterial occlusive disease, insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to air and moisture, so it must be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. This helps to preserve the efficacy and safety of the medication.

Appearance and packaging

Appearance

Pale yellow triangular film-coated tablets

Package unit

30 tablets / bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.